摘要
Abstract
Lower extremity atherosclerotic occlusive diseases, as one of atherosclerotic occlusive diseases, the incidence of which has been significantly increased. The continuous rise of cardiovascular risk factors such as hypertension, dyslipidemia, diabetes mellitus, smoking and so on are the main causes of the prevalence of arteriosclerosis occlusive disease in China. Therefore, prevention and treatment of arteriosclerosis occlusive disease should be based on the control of risk factors. Pharmacotherapy has a key role. Surgeons should pay more attention to clinical research in order to formulate the guidelines, based on which patients could receive standardized drug treatment, including anti-platelet, lipid-lowering, regulating blood sugar and blood pressure.The purposes are to delay the progress of arteriosclerosis, to improve the ischemic symptoms of the lower limb, to ensure the stent or graft’s patency rate, to reduce the incidence of cardiovascular and cerebrovascular events, and ultimately to improve the survival rate of patients.关键词
动脉硬化闭塞症/药物治疗Key words
atherosclerotic occlusive disease/pharmacotherapy分类
医药卫生
